116 related articles for article (PubMed ID: 20473329)
1. SIRPalpha1 receptors interfere with the EGFRvIII signalosome to inhibit glioblastoma cell transformation and migration.
Kapoor GS; O'Rourke DM
Oncogene; 2010 Jul; 29(29):4130-44. PubMed ID: 20473329
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs).
Wu CJ; Chen Z; Ullrich A; Greene MI; O'Rourke DM
Oncogene; 2000 Aug; 19(35):3999-4010. PubMed ID: 10962556
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of signal regulatory protein alpha1 inhibitory receptors by epidermal growth factor receptor signaling.
Kapoor GS; Kapitonov D; O'Rourke DM
Cancer Res; 2004 Sep; 64(18):6444-52. PubMed ID: 15374953
[TBL] [Abstract][Full Text] [Related]
4. Distinct domains in the SHP-2 phosphatase differentially regulate epidermal growth factor receptor/NF-kappaB activation through Gab1 in glioblastoma cells.
Kapoor GS; Zhan Y; Johnson GR; O'Rourke DM
Mol Cell Biol; 2004 Jan; 24(2):823-36. PubMed ID: 14701753
[TBL] [Abstract][Full Text] [Related]
5. SHP-2-dependent mitogen-activated protein kinase activation regulates EGFRvIII but not wild-type epidermal growth factor receptor phosphorylation and glioblastoma cell survival.
Zhan Y; O'Rourke DM
Cancer Res; 2004 Nov; 64(22):8292-8. PubMed ID: 15548697
[TBL] [Abstract][Full Text] [Related]
6. Recovery of anoikis in Src-transformed cells and human breast carcinoma cells by restoration of the SIRP α1/SHP-2 signaling system.
Hara K; Senga T; Biswas MH; Hasegawa H; Ito S; Hyodo T; Hirooka Y; Niwa Y; Goto H; Hamaguchi M
Cancer Res; 2011 Feb; 71(4):1229-34. PubMed ID: 21169408
[TBL] [Abstract][Full Text] [Related]
7. Negative regulation of hepatocellular carcinoma cell growth by signal regulatory protein alpha1.
Yan HX; Wang HY; Zhang R; Chen L; Li BA; Liu SQ; Cao HF; Qiu XH; Shan YF; Yan ZH; Wu HP; Tan YX; Wu MC
Hepatology; 2004 Sep; 40(3):618-28. PubMed ID: 15349900
[TBL] [Abstract][Full Text] [Related]
8. The protein tyrosine phosphatase SHP-2 is required for EGFRvIII oncogenic transformation in human glioblastoma cells.
Zhan Y; Counelis GJ; O'Rourke DM
Exp Cell Res; 2009 Aug; 315(14):2343-57. PubMed ID: 19427850
[TBL] [Abstract][Full Text] [Related]
9. Role of the Grb2-associated binder 1/SHP-2 interaction in cell growth and transformation.
Holgado-Madruga M; Wong AJ
Cancer Res; 2004 Mar; 64(6):2007-15. PubMed ID: 15026337
[TBL] [Abstract][Full Text] [Related]
10. Expression and activation of signal regulatory protein alpha on astrocytomas.
Chen TT; Brown EJ; Huang EJ; Seaman WE
Cancer Res; 2004 Jan; 64(1):117-27. PubMed ID: 14729615
[TBL] [Abstract][Full Text] [Related]
11. Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant III contributes to the neoplastic phenotype of glioblastoma multiforme.
Learn CA; Hartzell TL; Wikstrand CJ; Archer GE; Rich JN; Friedman AH; Friedman HS; Bigner DD; Sampson JH
Clin Cancer Res; 2004 May; 10(9):3216-24. PubMed ID: 15131063
[TBL] [Abstract][Full Text] [Related]
12. JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma.
Zheng Q; Han L; Dong Y; Tian J; Huang W; Liu Z; Jia X; Jiang T; Zhang J; Li X; Kang C; Ren H
Neuro Oncol; 2014 Sep; 16(9):1229-43. PubMed ID: 24861878
[TBL] [Abstract][Full Text] [Related]
13. Integrin-mediated tyrosine phosphorylation of SHPS-1 and its association with SHP-2. Roles of Fak and Src family kinases.
Tsuda M; Matozaki T; Fukunaga K; Fujioka Y; Imamoto A; Noguchi T; Takada T; Yamao T; Takeda H; Ochi F; Yamamoto T; Kasuga M
J Biol Chem; 1998 May; 273(21):13223-9. PubMed ID: 9582366
[TBL] [Abstract][Full Text] [Related]
14. Regulation of early events in integrin signaling by protein tyrosine phosphatase SHP-2.
Oh ES; Gu H; Saxton TM; Timms JF; Hausdorff S; Frevert EU; Kahn BB; Pawson T; Neel BG; Thomas SM
Mol Cell Biol; 1999 Apr; 19(4):3205-15. PubMed ID: 10082587
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of dedicator of cytokinesis 1 (Dock180) at tyrosine residue Y722 by Src family kinases mediates EGFRvIII-driven glioblastoma tumorigenesis.
Feng H; Hu B; Jarzynka MJ; Li Y; Keezer S; Johns TG; Tang CK; Hamilton RL; Vuori K; Nishikawa R; Sarkaria JN; Fenton T; Cheng T; Furnari FB; Cavenee WK; Cheng SY
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3018-23. PubMed ID: 22323579
[TBL] [Abstract][Full Text] [Related]
16. Effect of Sirpalpha1 on the expression of nuclear factor-kappa B in hepatocellular carcinoma.
Qin JM; Wan XW; Zeng JZ; Wu MC
Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):276-83. PubMed ID: 17548251
[TBL] [Abstract][Full Text] [Related]
17. IL-2, but not IL-4 and other cytokines, induces phosphorylation of a 98-kDa protein associated with SHP-2, phosphatidylinositol 3'-kinase, and Grb2.
Gadina M; Sudarshan C; O'Shea JJ
J Immunol; 1999 Feb; 162(4):2081-6. PubMed ID: 9973481
[TBL] [Abstract][Full Text] [Related]
18. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
[TBL] [Abstract][Full Text] [Related]
19. Role of SHPS-1 in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells.
Ling Y; Maile LA; Lieskovska J; Badley-Clarke J; Clemmons DR
Mol Biol Cell; 2005 Jul; 16(7):3353-64. PubMed ID: 15888547
[TBL] [Abstract][Full Text] [Related]
20. Neutralizing the EGF receptor in glioblastoma cells stimulates cell migration by activating uPAR-initiated cell signaling.
Hu J; Muller KA; Furnari FB; Cavenee WK; VandenBerg SR; Gonias SL
Oncogene; 2015 Jul; 34(31):4078-88. PubMed ID: 25347738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
